期刊文献+

解读中国帕金森病治疗指南 被引量:7

The interpretation of Chinese guideline for lhe treatment of Parkinson's disease.
收藏 分享 导出
摘要 中华医学会神经病学分会在2009年发表了《中国帕金森病治疗指南(第二版)》。该指南根据国内外循证医学证据对于帕金森病治疗的有关内容进行了分析,具体包括药物治疗的原则、开始治疗的时机、选择药物的依据、不同阶段的治疗策略。对于中晚期帕金森病合并运动并发症的治疗进行了详细的总结;提出了治疗帕金森病非运动症状的初步建议;对于帕金森病手术治疗的适应证、时机等进行了分析。 The Chinese guideline of Parkinson's disease (PD) make evidence-based treatment recommendations for the medical and surgical treatment of patients with Parkinson disease. The available evidence establish superiority of continuous dopaminergic stimulation in reducing levodopa-induced motor fluctuations and dyskinesia. Nonmotor symptoms ( sleep dysfunction, sensory symptoms, autonomic dysfunction, mood disorders, and cognitive abnormalities) in Parkinson disease are a major cause of morbidity. This evidence-based practice parameter evaluates treatment options for the nonmotor symptoms of PD. Deep brain stimulation of the STN may be considered to improve motor function and reduce off time,dyskinesia,and medication usage.
作者 冯涛 FENG Tao.( Department of Neurology,Beijing Tiantan Hospital, Capital Medical University,BeiJing 100050, China)
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第11期986-988,共3页 Chinese Journal of Practical Internal Medicine
关键词 帕金森病 药物 治疗 Parkinson's disease treatment drug
作者简介 冯涛,主任医师、教授、硕士生导师。首都医科大学附属北京天坛医院神经内科。主要从事神经系统退行性病变的临床研究。近年致力于帕金森病、阿尔茨海默病的生物学标记物研究以及神经调控治疗。目前承担省部级基金课题4项。曾获得全军科技进步奖、北京市科技进步奖和全国优秀论文奖共5项。兼任《中国实用内科杂志》等3种核心期刊编委。在国内外发表中英文文章70余篇,其中以第一作者在SCI期刊发表4篇。电子信箱:happyfi@sina.com
  • 相关文献

参考文献10

  • 1中国帕金森病治疗指南(第二版)[J].中华神经科杂志,2009,42(5):352-355. 被引量:137
  • 2Horstink M,Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I : early ( uncomplicated) Parkinson's disease [ J]. Eur J Neurol, 2006, 13 ( 11 ) : 1170-1185. 被引量:1
  • 3Baker WL, Silver D, White CM, et al. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis [ J ]. Parkinsonism Relat Disord ,2009,15 (4) :287 - 294. 被引量:1
  • 4Simonis G, Fuhrmann JT,Strasser RH. Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists[ J]. Mov Disord ,2007,22( 13 ) : 1936 - 1942. 被引量:1
  • 5Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease [ J ]. Eur J Neurol, 2006,13 ( 11 ) :1186 - 1202. 被引量:1
  • 6冯涛,王拥军,.持续性多巴胺能刺激治疗帕金森病的研究进展[J].临床神经病学杂志,2008(4):315-317. 被引量:4
  • 7Pahwa R, Factor SA, Lyons KE, et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review) : report of the Quality Standards Subcommittee of the American Academy of Neurology[ J ]. Neurology, 2006,66 (7) :983 - 995. 被引量:1
  • 8Aarsland D, Emre M, Lees A, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease ( an evidence-based review) : report of the Quality Stand- ards Subcommittee of the American Academy of Neurology [ J ]. Neurology ,2007,68 ( 1 ) :80. 被引量:1
  • 9Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease : report of the Quality Standards Subcommittee of the American Academy of Neurology[ J]. Neurology,2010,74( 11 ) :924 -931. 被引量:1
  • 10Benabid AL, Chabardes S, Mitrofanis J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease [ J ]. Lancet Neurol,2009,8 ( 1 ) :67 - 81. 被引量:1

二级参考文献35

  • 1陈生弟,.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:76
  • 2温洪波,张振馨,罗毅,陈生弟,蒋雨平,张小英,孙相如,王新德,姚晨.普拉克索治疗帕金森病的多中心、随机、双盲、溴隐亭对照临床疗效和安全性研究[J].中华神经科杂志,2006,39(9):604-608. 被引量:56
  • 3Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson' s disease. N Engl J Med, 1993, 328 : 176-183. 被引量:1
  • 4Hauser RA, Lew MF, Hurtig HI, et al. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson' s disease. Mov Disord, 2008, 24:562-571. 被引量:1
  • 5Bonuccelli U, Pavese N. Role of dopamine agonists in Parkinson' s disease : an update. Expert Rev Neurother, 2007, 7 : 1391-1399. 被引量:1
  • 6Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 2002, 59 : 1541-1550. 被引量:1
  • 7Albin RL, Frey KA. Initial agonist treatment of Parkinson disease : a critique. Neurology, 2003, 60 : 390-394. 被引量:1
  • 8Olanow W, Schapira AH, Rascol O. Continuous dopamine- receptor stimulation in early Parkinson' s disease. Trends Neurosci, 2000, 23 ( 10 Suppl) : Sl17-126. 被引量:1
  • 9Olanow CW, Watts RL, Koller WC. An algorithm ( decision tree) for the management of Parkinson' s disease ( 2001 ) : treatment guidelines. Neurology, 2001,56 ( 11 Suppl 5 ) : S1-S88. 被引量:1
  • 10Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson' s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I : early (uncomplicated) Parkinson' s disease. Eur J Neurol, 2006, 13 : 1170-1185. 被引量:1

共引文献138

同被引文献116

引证文献7

二级引证文献19

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈